Virtual Pharma Symposium by BASF June 16-18, 2020
Join experts from the pharmaceutical industry for a free 3-day webcast series. Each day a specific pharma-related topic will be discussed, and the audience will have the opportunity to ask questions directly to the experts. Each session has a duration of 2 hours. The following topics will be covered:
Formulations for Sustained Release Tablets via Matrix Systems – From Direct Compression to 3D Printing Technologies
Tuesday, June 16, 2020, 10:00 AM EDT – Register here for free
Unlock the full potential of poorly soluble drug using ready-to-use SEDDS compositions & Introducing superSNEDDS – as way of increasing the applicability of lipid-based drug delivery systems
Wednesday, June 17, 2020, 10:00 AM EDT – Register here for free
Modifying API permeation through human skin with lipid-based oleochemical excipients & Using Lipidic Excipients to Enhance Drug Permeation in Topical Cream Products
Thursday, June 18, 2020, 10:00 AM EDT – Register here for free
More information on the presentations
Formulations for Sustained Release Tablets via Matrix Systems – From Direct Compression to 3D Printing Technologies
The presenters will focus on different formulation technologies for creating sustained release tablets with matrix excipients processed via direct compression or hot melt extrusion (HME) with 3D printing technologies.
Dr. Krizia M. Karry – BASF Global Technical Marketing Manager
Dr. Suresh Bandari – Research Scientist at University of Mississippi Department of Pharmaceutics & Drug Delivery
Unlock the full potential of poorly soluble drug using ready-to-use SEDDS compositions & Introducing superSNEDDS – as way of increasing the applicability of lipid-based drug delivery systems
1. Unlock the full potential of poorly soluble drug using ready-to-use SEDDS compositions
There is no one-size-fits-all solution to solubilization, but the industry is increasingly investigating practical solutions. BASF has designed 10 unique Self-Emulsifying Drug Delivery Systems (SEDDS), which can be easily reproduced to evaluate solubilization capability and bioavailability improvement for lead compounds at various product development stages. The presenter will discuss how they found the following:
- Proper balance of formulation components is critical for complex systems
- LBDDS formulations, specifically SEDDS, are highly dependent on excipients and their functionalities
- Kolliphor® RH 40, and Kolliphor® EL are highly effective at making SEDDS
Dr. Nitin Kumar Swarnakar – BASF Global Technical Marketing Scientist
2. Introducing superSNEDDS – as way of increasing the applicability of lipid-based drug delivery systems
Oral self-nanoemulsifying drug delivery systems (SNEDDS) have proven to increase the absorption of poorly soluble drugs. A frequent shortcoming is the relatively low drug dose that can be dissolved in the SNEDDS, thereby reducing their potential. The presenter will discuss 1) the different ways to increase the achievable drug dose in SNEDDS, such that the SNEDDS application can be more versatile and 2) the considerations required when developing in vitro models for predicting SNEDDS performance.
Dr. Anette Müllertz – Professor, Physiological Pharmaceutics Department of Pharmacy, Faculty of Health
and Medical Sciences, University of Copenhagen
Modifying API permeation through human skin with lipid-based oleochemical excipients & Using Lipidic Excipients to Enhance Drug Permeation in Topical Cream Products
As topical semisolid dosage forms continue to grow in popularity, lipid-based oleochemical use has become increasingly prevalent due to their ability to modify skin permeation, resulting in enhanced therapeutic efficacy of some dermatological drugs. The presenters will discuss how they employed qualitative and quantitative methods to identify potential excipients for improving topical and transdermal drug delivery.
Benjamin Goodyear- BASF Global Technical Marketing Manager
Dr. Narasimha Murthy – Professor at University of Mississippi